Wellcome Trust – Infectious Disease Award: Understanding dengue and Zika spread, immunity and clinical outcomes
Event details
| Date | 25.06.2024 |
| Category | Call for proposal |
This funding call will support multidisciplinary teams to generate evidence on where dengue and Zika viruses co-circulate and investigate the implications this has on host immune responses and clinical outcomes. Research funded through this award will support global efforts to understand and predict the spread of these pathogens, especially where data are limited. Funded projects will also help to design and implement future interventions to reduce dengue and Zika’s growing burden and impact on health.
Priority for funding will be given to proposals that consider the co-circulation of the two viruses and include:
- Investigations of immunological cross-reactivity of dengue and Zika.
- Molecular and clinical epidemiology studies of dengue and Zika to improve the understanding of the co-circulation of the two viruses, their viral diversity and clinical outcomes.
The award must be held by a team of researchers led by an established team leader from an eligible administering institution.
The team must:
- Contain expertise in whole genome sequencing and analysis, and at least one of the following disciplines: epidemiology, immunology or public health.
- Have a lead applicant or co-applicant from an African or Asian country that is currently experiencing a dengue and Zika outbreak or has experienced an outbreak in the past.
- Include either a lead applicant or co-applicants based in each country where the research will take place.
- Include public health stakeholders and policymakers in the country where the research is conducted.
Funding: up to £ 5M
Duration: up to 5 years
Eligibility:
Eligible organisations can be higher education institutions, research institutes, non-academic healthcare organisations, not-for-profit or non-governmental organisations. The host organisation of the lead applicant Be based anywhere in the world except mainland China, with at least one coapplicant based at an institution in an African or Asian country that is currently experiencing a dengue and Zika outbreak or has experienced an outbreak in the past.
Lead applicant and Co-applicant criteria can found be here.
How to Apply:
Applications should be completed through Wellcome’s online portal. The full proposal submission requires authorization by the host institution, please do bear that in mind and notify the Research Office that you are applying well in advance of submission.
Deadline, preliminary application: 25 June 2024
Further information:
- More information about the program is available here
- Webinar on 16 May, registration here
- The application portal can be found here
For any other questions, please contact the Research Office
Practical information
- General public
- Free